Using metabolomic analysis to understand inflammatory bowel diseases.
about
Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activityUrinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical reviewNutritional Modulation of Gene Expression: Might This be of Benefit to Individuals with Crohn's Disease?Microbiome analysis - from technical advances to biological relevanceMetabolomics and its potential in diagnosis, prognosis and treatment of rheumatic diseasesLaboratory markers in ulcerative colitis: Current insights and future advancesBovine immunoglobulin protein isolates for the nutritional management of enteropathyDistinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet.Alteration of the fecal microbiota and serum metabolite profiles in dogs with idiopathic inflammatory bowel diseaseBiomarkers in inflammatory bowel disease: current practices and recent advances.Metabolomic applications to decipher gut microbial metabolic influence in health and diseaseQuantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individualsClinical metabolomics paves the way towards future healthcare strategies.Metabolomics: is it useful for inflammatory bowel diseases?Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseasesCandidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology.Potential value of nutrigenomics in Crohn's disease.Towards personalized care in IBD.Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.Metabolite profiling of plasma and urine from rats with TNBS-induced acute colitis using UPLC-ESI-QTOF-MS-based metabonomics--a pilot study.Metabolomics of human intestinal transplant rejection.Serum metabolic profiling in inflammatory bowel disease.Polysaccharides From Ramat Ameliorate Colitis Rats via Regulation of the Metabolic Profiling and NF-κ B/TLR4 and IL-6/JAK2/STAT3 Signaling Pathways
P2860
Q24658606-8A8E23D8-FCCC-4F83-BA96-83F15E025452Q26748735-4B3BF10B-D8C3-40FB-A1E4-CE0648406727Q26781298-C20FD8D4-FBF5-4871-823B-816D5CBB0B1DQ26849411-E15E4A50-4669-4564-B4A6-F06F73DE2471Q27022390-8DBFCFEA-6202-4741-B9A7-00E8A99DEE77Q27027022-AC62E314-64FF-40BF-8FE0-AB34498D2D0AQ27027910-B95F74E6-14DB-43C1-AAB8-677FD2D09E82Q34662057-3274B08A-A3B3-4823-B3A1-18796D70E071Q35532259-E8FD12CF-BB91-4467-9D55-3094163CB05CQ35840853-C483BFA7-3DCF-4794-816F-E27781EC6413Q35914935-6E46660B-1498-47A6-AB18-5069776AB934Q36570929-1CF1C8F2-E08A-4065-A473-69E0FD547F7FQ36620171-A12EC075-9C9F-4B83-815F-AD0C0DF8725DQ36955885-933C4A2E-ABDC-4213-A49C-7D8D2D3A09A6Q37454433-6B4C5739-5C61-423A-B5FC-D88E537FB514Q37951110-4629B81A-CE0E-4036-B369-8D41CA3A0F64Q37992788-50DFA957-D8D5-4004-BA4C-D2BBB021ADDFQ38171924-46221841-7539-41BF-86D4-9208D862EFE8Q38230162-0CDB6968-CC84-4234-8C0D-E886166D4479Q44004594-C898C195-5444-4AF0-811B-0E19BC81F2C3Q47423531-2598779F-7016-40FE-8148-7CFD128EC1E5Q49162097-B05FAE28-26FF-499C-9010-5FD9604558CDQ57115083-87737A64-9CE7-4717-A893-80EE8A3F5142
P2860
Using metabolomic analysis to understand inflammatory bowel diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Using metabolomic analysis to understand inflammatory bowel diseases.
@en
Using metabolomic analysis to understand inflammatory bowel diseases.
@nl
type
label
Using metabolomic analysis to understand inflammatory bowel diseases.
@en
Using metabolomic analysis to understand inflammatory bowel diseases.
@nl
prefLabel
Using metabolomic analysis to understand inflammatory bowel diseases.
@en
Using metabolomic analysis to understand inflammatory bowel diseases.
@nl
P2860
P356
P1476
Using metabolomic analysis to understand inflammatory bowel diseases
@en
P2093
Daryl D Rowan
Lynnette R Ferguson
P2860
P304
P356
10.1002/IBD.21426
P577
2011-04-01T00:00:00Z